BRAF and colorectal cancer: In contrast to colorectal cancer cells expressing mutant K-RAS, cell lines that express mutant B-RAF were sensitive to inhibition of MEK and treatment with CI-1040 induced G1 arrest [6] (Fig. 1b, c).